Literature DB >> 21930712

Ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) protein regulates osteoblast differentiation.

Hwa Kyung Nam1, Jin Liu, Yan Li, Andrew Kragor, Nan E Hatch.   

Abstract

ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase-1) is an established regulator of tissue mineralization. Previous studies demonstrated that ENPP1 is expressed in differentiated osteoblasts and that ENPP1 influences matrix mineralization by increasing extracellular levels of inorganic pyrophosphate. ENPP1 is also expressed in osteoblastic precursor cells when stimulated with FGF2, but the role of ENPP1 in preosteoblastic and other precursor cells is unknown. Here we investigate the function of ENPP1 in preosteoblasts. We find that ENPP1 expression is critical for osteoblastic differentiation and that this effect is not mediated by changes in extracellular concentration levels of phosphate or pyrophosphate or ENPP1 catalytic activity. MC3T3E1(C4) preosteoblastic cells, in which ENPP1 expression was suppressed by ENPP1-specific shRNA, and calvarial cells isolated from Enpp1 knock-out mice show defective osteoblastic differentiation upon stimulation with ascorbate, as indicated by a lack of cellular morphological change, a lack of osteoblast marker gene expression, and an inability to mineralize matrix. Additionally, MC3T3E1(C4) cells, in which wild type or catalytic inactive ENPP1 expression was increased, exhibited an increased tendency to differentiate, as evidenced by increased osteoblast marker gene expression and increased mineralization. Notably, treatment of cells with inorganic phosphate or pyrophosphate inhibited, as opposed to enhanced, expression of multiple genes that are expressed in association with osteoblast differentiation, matrix deposition, and mineralization. Our results indicate that ENPP1 plays multiple and distinct roles in the development of mineralized tissues and that the influence of ENPP1 on osteoblast differentiation and gene expression may include a mechanism that is independent of its catalytic activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21930712      PMCID: PMC3234731          DOI: 10.1074/jbc.M111.221689

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Nucleotide pyrophosphatase gene polymorphism associated with ossification of the posterior longitudinal ligament of the spine.

Authors:  Yu Koshizuka; Hiroshi Kawaguchi; Naoshi Ogata; Toshiyuki Ikeda; Akihiko Mabuchi; Atsushi Seichi; Yusuke Nakamura; Kozo Nakamura; Shiro Ikegawa
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

2.  The nucleoside triphosphate pyrophosphohydrolase isozyme PC-1 directly promotes cartilage calcification through chondrocyte apoptosis and increased calcium precipitation by mineralizing vesicles.

Authors:  K Johnson; K Pritzker; J Goding; R Terkeltaub
Journal:  J Rheumatol       Date:  2001-12       Impact factor: 4.666

3.  Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification.

Authors:  Frank Rutsch; Nico Ruf; Sucheta Vaingankar; Mohammad R Toliat; Anita Suk; Wolfgang Höhne; Galen Schauer; Mandy Lehmann; Tony Roscioli; Dirk Schnabel; Jörg T Epplen; Alex Knisely; Andrea Superti-Furga; James McGill; Marco Filippone; Alan R Sinaiko; Hillary Vallance; Bernd Hinrichs; Wendy Smith; Merry Ferre; Robert Terkeltaub; Peter Nürnberg
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

4.  FGF2 alters expression of the pyrophosphate/phosphate regulating proteins, PC-1, ANK and TNAP, in the calvarial osteoblastic cell line, MC3T3E1(C4).

Authors:  Nan E Hatch; Francisco Nociti; Erica Swanson; Mark Bothwell; Martha Somerman
Journal:  Connect Tissue Res       Date:  2005       Impact factor: 3.417

5.  Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization.

Authors:  Lovisa Hessle; Kristen A Johnson; H Clarke Anderson; Sonoko Narisawa; Adnan Sali; James W Goding; Robert Terkeltaub; José Luis Millan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

6.  Purification and properties of a mouse liver plasma-membrane glycoprotein hydrolysing nucleotide pyrophosphate and phosphodiester bonds.

Authors:  W H Evans; D O Hood; J W Gurd
Journal:  Biochem J       Date:  1973-12       Impact factor: 3.857

7.  Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine.

Authors:  A Okawa; I Nakamura; S Goto; H Moriya; Y Nakamura; S Ikegawa
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

8.  Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders.

Authors:  Dympna Harmey; Lovisa Hessle; Sonoko Narisawa; Kristen A Johnson; Robert Terkeltaub; José Luis Millán
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

9.  Causal link between nucleotide pyrophosphohydrolase overactivity and increased intracellular inorganic pyrophosphate generation demonstrated by transfection of cultured fibroblasts and osteoblasts with plasma cell membrane glycoprotein-1. Relevance to calcium pyrophosphate dihydrate deposition disease.

Authors:  R Terkeltaub; M Rosenbach; F Fong; J Goding
Journal:  Arthritis Rheum       Date:  1994-06

10.  Role of ENPP1 on adipocyte maturation.

Authors:  Jian Liang; Mingui Fu; Ester Ciociola; Manisha Chandalia; Nicola Abate
Journal:  PLoS One       Date:  2007-09-12       Impact factor: 3.240

View more
  30 in total

Review 1.  Heritable and acquired disorders of phosphate metabolism: Etiologies involving FGF23 and current therapeutics.

Authors:  Erica L Clinkenbeard; Kenneth E White
Journal:  Bone       Date:  2017-01-31       Impact factor: 4.398

2.  Intersection of complex genetic traits affecting maternal metabolism, fetal metabolism, and neural tube defect risk: looking for needles in multiple haystacks.

Authors:  Mary R Loeken
Journal:  Mol Genet Metab       Date:  2014-01-25       Impact factor: 4.797

3.  GATA2 regulates differentiation of bone marrow-derived mesenchymal stem cells.

Authors:  Mayumi Kamata; Yoko Okitsu; Tohru Fujiwara; Masahiko Kanehira; Shinji Nakajima; Taro Takahashi; Ai Inoue; Noriko Fukuhara; Yasushi Onishi; Kenichi Ishizawa; Ritsuko Shimizu; Masayuki Yamamoto; Hideo Harigae
Journal:  Haematologica       Date:  2014-08-22       Impact factor: 9.941

Review 4.  Hypophosphatemic rickets: revealing novel control points for phosphate homeostasis.

Authors:  Kenneth E White; Julia M Hum; Michael J Econs
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

5.  NPP1 is responsible for potent extracellular ATP hydrolysis as NTPDase1 in primary cultured murine microglia.

Authors:  Hye Min Lim; Woon Heo; Jung Woo Han; Min Goo Lee; Joo Young Kim
Journal:  Purinergic Signal       Date:  2018-03-07       Impact factor: 3.765

6.  Enhanced mineralization potential of vascular cells from SM22α-Rankl (tg) mice.

Authors:  S Morony; A P Sage; T Corbin; J Lu; Y Tintut; L L Demer
Journal:  Calcif Tissue Int       Date:  2012-10-09       Impact factor: 4.333

7.  Phosphate enhances reactive oxygen species production and suppresses osteoblastic differentiation.

Authors:  Takaaki Okamoto; Manabu Taguchi; Tomoko Osaki; Seiji Fukumoto; Toshiro Fujita
Journal:  J Bone Miner Metab       Date:  2013-09-20       Impact factor: 2.626

8.  Overlapping functions of bone sialoprotein and pyrophosphate regulators in directing cementogenesis.

Authors:  M Ao; M B Chavez; E Y Chu; K C Hemstreet; Y Yin; M C Yadav; J L Millán; L W Fisher; H A Goldberg; M J Somerman; B L Foster
Journal:  Bone       Date:  2017-09-01       Impact factor: 4.398

Review 9.  Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy.

Authors:  Jean Pierre Salles
Journal:  Clin Biochem Rev       Date:  2020-02

10.  Tissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the Alpl(-/-) mouse model of infantile hypophosphatasia.

Authors:  Jin Liu; Hwa Kyung Nam; Cassie Campbell; Kellen Cristina da Silva Gasque; José Luis Millán; Nan E Hatch
Journal:  Bone       Date:  2014-07-09       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.